Literature DB >> 24184382

Nuclear receptors as regulators of stem cell and cancer stem cell metabolism.

Zoltan Simandi1, Ixchelt Cuaranta-Monroy, Laszlo Nagy.   

Abstract

Cellular metabolism is underpinning physiological processes in all cells. These include housekeeping functions as well as specific activities unique to a particular cell type. A growing number of studies in various experimental models indicate that metabolism is tightly connected to embryonic development as well. It is also emerging that metabolic processes have regulatory roles and by changing metabolism, cellular processes and even fates can be influenced. Nuclear receptors (NRs) are transcription factors, responding to changes in metabolites and are implicated in diverse biological processes such as embryonic development, differentiation, metabolism and cancer. Therefore, NRs are key links between metabolism and cell fate decisions. In this review, we introduce ESRRβ, DAX-1 and LRH-1 as putative regulators of metabolism in pluripotent embryonic stem cells. We also discuss the role of TR4, NGF1β, LXRβ and RARs in stemness. In addition, we summarize our current understanding of the potential roles of NRs in cancer stem cells.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cancer stem cells; Embryonic stem cells; Metabolism; Nuclear receptors; Pluripotency

Mesh:

Substances:

Year:  2013        PMID: 24184382     DOI: 10.1016/j.semcdb.2013.10.002

Source DB:  PubMed          Journal:  Semin Cell Dev Biol        ISSN: 1084-9521            Impact factor:   7.727


  2 in total

1.  TR4 Nuclear Receptor Alters the Prostate Cancer CD133+ Stem/Progenitor Cell Invasion via Modulating the EZH2-Related Metastasis Gene Expression.

Authors:  Jin Zhu; Dong-Rong Yang; Yin Sun; Xiaofu Qiu; Hong-Chiang Chang; Gonghui Li; Yuxi Shan; Chawnshang Chang
Journal:  Mol Cancer Ther       Date:  2015-04-01       Impact factor: 6.261

2.  GATA6 enhances the stemness of human colon cancer cells by creating a metabolic symbiosis through upregulating LRH-1 expression.

Authors:  Hung-Tzu Lai; Chin-Ting Chiang; Wen-Ko Tseng; Ta-Chung Chao; Yeu Su
Journal:  Mol Oncol       Date:  2020-02-26       Impact factor: 6.603

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.